Literature DB >> 8298653

Characterization of molecular defects in xeroderma pigmentosum group C.

L Li1, E S Bales, C A Peterson, R J Legerski.   

Abstract

Xeroderma pigmentosum (XP) is a rare autosomal recessive disease of humans characterized by an accelerated chronic degeneration of sun-exposed areas of the body, including an elevated risk of developing cancers of the skin. We recently reported the isolation of a gene XPCC that complements the repair deficiency of cultured XP-C cells. Here we report the results of a characterization of XPCC at the nucleotide level in five XP-C cell lines. Each cell line exhibited a unique mutation that correlated well with the cellular DNA repair deficiency and the clinical severity of the disease. These results extend our previous observations and indicate that defects in XPCC cause Xeroderma pigmentosum group C.

Entities:  

Mesh:

Year:  1993        PMID: 8298653     DOI: 10.1038/ng1293-413

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  30 in total

1.  Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population.

Authors:  Jennifer Pugh; Sikandar G Khan; Deborah Tamura; Alisa M Goldstein; Maria Teresa Landi; John J DiGiovanna; Kenneth H Kraemer
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

2.  Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC.

Authors:  Bruno M Bernardes de Jesus; Magnar Bjørås; Frédéric Coin; Jean Marc Egly
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

3.  HHR23B, a human Rad23 homolog, stimulates XPC protein in nucleotide excision repair in vitro.

Authors:  K Sugasawa; C Masutani; A Uchida; T Maekawa; P J van der Spek; D Bootsma; J H Hoeijmakers; F Hanaoka
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  XPC and human homologs of RAD23: intracellular localization and relationship to other nucleotide excision repair complexes.

Authors:  P J van der Spek; A Eker; S Rademakers; C Visser; K Sugasawa; C Masutani; F Hanaoka; D Bootsma; J H Hoeijmakers
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

5.  Identification and characterization of XPC-binding domain of hHR23B.

Authors:  C Masutani; M Araki; K Sugasawa; P J van der Spek; A Yamada; A Uchida; T Maekawa; D Bootsma; J H Hoeijmakers; F Hanaoka
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

6.  The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts.

Authors:  S Emmert; N Kobayashi; S G Khan; K H Kraemer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

7.  Characterisation of novel mutations in Cockayne syndrome type A and xeroderma pigmentosum group C subjects.

Authors:  Andrew J Ridley; James Colley; David Wynford-Thomas; Christopher J Jones
Journal:  J Hum Genet       Date:  2005-03-03       Impact factor: 3.172

8.  Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons.

Authors:  Christiane Kuschal; John J DiGiovanna; Sikandar G Khan; Richard A Gatti; Kenneth H Kraemer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

9.  XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.

Authors:  Sikandar G Khan; Kyu-Seon Oh; Steffen Emmert; Kyoko Imoto; Deborah Tamura; John J Digiovanna; Tala Shahlavi; Najealicka Armstrong; Carl C Baker; Marcy Neuburg; Chris Zalewski; Carmen Brewer; Edythe Wiggs; Raphael Schiffmann; Kenneth H Kraemer
Journal:  DNA Repair (Amst)       Date:  2008-11-14

10.  XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.

Authors:  Sikandar G Khan; Koji Yamanegi; Zhi-Ming Zheng; Jennifer Boyle; Kyoko Imoto; Kyu-Seon Oh; Carl C Baker; Engin Gozukara; Ahmet Metin; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.